Freeze, drug, and save: new combo aims to spare bladders from cancer surgery
NCT ID NCT07204132
Summary
This study is testing a new combination treatment designed to control high-risk bladder cancer while allowing patients to keep their bladder. It combines a precise freezing technique performed during tumor removal with immunotherapy and low-dose chemotherapy. The goal is to see if this approach is as effective as or better than the standard surgery to remove the entire bladder, with the hope of improving patients' quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ChangHai Hospital
RECRUITINGShanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.